Barclays PLC Haleon PLC Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Haleon PLC stock. As of the latest transaction made, Barclays PLC holds 1,500 shares of HLN stock, worth $14,085. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,500

Previous 1,500 -0.0%

Holding current value

$14,085

Previous $12,000 33.33%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$8.02 - $8.67 $56,131 - $60,681	-6,999 Reduced 82.35%	1,500 $13,000
Q4 2023 Feb 15, 2024	BUY	$7.78 - $8.62 $33,337 - $36,936	4,285 Added 101.68%	8,499 $70,000
Q3 2023 Nov 07, 2023	BUY	$7.85 - $8.94 $7,041 - $8,019	897 Added 27.04%	4,214 $34,000
Q2 2023 Aug 03, 2023	BUY	$8.04 - $9.0 $9,615 - $10,764	1,196 Added 56.39%	3,317 $28,000
Q1 2023 May 04, 2023	BUY	$7.57 - $8.37 $757 - $836	100 Added 4.95%	2,121 $17,000
Q4 2022 Feb 13, 2023	BUY	$5.96 - $8.06 $1,788 - $2,418	300 Added 17.43%	2,021 $16,000
Q3 2022 Nov 03, 2022	BUY	$5.63 - $7.5 $9,689 - $12,907	1,721 New	1,721 $11,000

Others Institutions Holding HLN

# of Institutions

638

Shares Held

412M

Call Options Held

149K

Put Options Held

16K

View Full List

About Haleon plc

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $43.4B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

More about HLN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account